NCT06327997View on ClinicalTrials.gov

An Exploratory Study by Fast CAR T Cells

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 7, 2024

Primary Completion Date

March 6, 2027

Study Completion Date

December 31, 2027

Conditions
Solid Tumor
Interventions
BIOLOGICAL

Fast CAR T cells

This study designed three dose groups, each with a dosage of 5.0 × 10\^5/kg、1.0×10\^6/kg、5.0×10\^6/kg

Trial Locations (1)

Unknown

RECRUITING

Shanghai Mengchao Cancer Hospital, Shanghai

All Listed Sponsors
lead

Shanghai Cell Therapy Group Co.,Ltd

INDUSTRY